EDGAR Filing Documents for 0001683168-20-000317

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001683168-20-000317

Filing Date

2020-01-31

Accepted

2020-01-31 17:28:18

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT #1 TO REGISTRATION STATEMENT	phio_s1a1.htm	S-1/A	454582
2	FORM OF UNDERWRITING AGREEMENT	phio_ex0101.htm	EX-1.1	293892
3	FORM OF COMMON STOCK PURCHASE WARRANT	phio_ex0407.htm	EX-4.7	114911
4	FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT	phio_ex0408.htm	EX-4.8	112283
5	FORM OF UNDERWRITER COMMON STOCK PURCHASE WARRANT	phio_ex0409.htm	EX-4.9	119803
6	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	phio_ex2301.htm	EX-23.1	2509
7	GRAPHIC	image_001.jpg	GRAPHIC	2792
	Complete submission text file	0001683168-20-000317.txt		1103060

Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752

Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861

Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)